OMDA Omada Health, Inc. - Common Stock
$16.77
价格 · 五月 20, 2026
截至...的财报数据 五月 8, 2026
52周区间
$11–$28
34% of range
分析师评级
BUY
18 analysts
目标价
$23
+37% upside
P/E (TTM)
-45.1
ROE
-5.8%
净利润率
-4.9%
OMDA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$16.77
市值
$922M
P/E (TTM)
-45.1
每股收益 (TTM)
$-0.35
营收 (TTM)
$260M
股息收益率
—
ROE
-5.8%
负债/权益
—
52周区间
$11 – $28
OMDA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$260M
2023-12-31
→
2025-12-31
EPS
$-0.35
2023-12-31
→
2025-12-31
自由现金流
$17M
2025-12-31
→
2025-12-31
利润率
-4.9%
2025-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
OMDA
同行中位数
P/E (TTM)
-45.1
42.0
P/S (TTM) (市销率 (TTM))
3.5
1.2
P/B (市净率)
4.0
2.7
Price / FCF (股价/自由现金流)
54.5
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
OMDA
同行中位数
Gross Margin (毛利率)
65.7%
32.5%
Operating Margin (营业利润率)
-4.6%
—
Net Profit Margin (净利润率)
-4.9%
2.0%
ROA
-5.6%
2.5%
ROE
-5.8%
6.3%
ROIC
-5.2%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
OMDA
同行中位数
Current Ratio (流动比率)
3.6
1.5
Quick Ratio (速动比率)
3.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
OMDA
同行中位数
Revenue YoY (营收同比增长)
53.2%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
OMDA
同行中位数
OMDA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
18 位分析师
- 强烈买入 2 11.1%
- 买入 13 72.2%
- 持有 3 16.7%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
12 位分析师 · 2026-05-20
中位数
$22.50
现在
$16.77
最低
$15.00
最高
$30.00
中位数目标
$22.50
+34.2%
平均目标
$23.00
+37.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.05%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.05 | $-0.08 | 0.03% |
| 2025年12月31日 | $0.08 | $-0.05 | 0.13% |
| 2025年9月30日 | $-0.06 | $-0.08 | 0.02% |
| 2025年6月30日 | $-0.24 | $-0.26 | 0.01% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| WGS | — | — | — | — | — | — |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | — |
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
| OPK | — | -4.2 | -14.9% | -37.2% | -17.6% | 33.9% |
| TALK | — | — | — | — | — | — |
| LMRI | — | — | — | — | — | — |
| CSTL | $1.15B | -46.9 | 3.7% | -7.0% | -5.2% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $260M | $170M | $123M | |
| Cost of Revenue | $89M | $67M | $53M | |
| Gross Profit | $171M | $103M | $70M | |
| R&D Expense | $41M | $36M | $34M | |
| SG&A Expense | $52M | $43M | $36M | |
| Operating Expenses | $183M | $147M | $136M | |
| Operating Income | $-12M | $-44M | $-66M | |
| Interest Income | $5M | $805.0K | $6M | |
| Other Non-op | $-806.0K | $-3M | $-2M | |
| Pretax Income | $-13M | $-47M | $-68M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-13M | $-47M | $-68M | |
| EPS (Basic) | $-0.35 | $-6.11 | $-9.52 | |
| EPS (Diluted) | $-0.35 | $-6.11 | $-9.52 | |
| Shares (Basic) | 36,639,000 | 7,721,000 | 7,091,000 | |
| Shares (Diluted) | 36,639,000 | 7,721,000 | 7,091,000 | |
| EBITDA | $-6M | · | · |
资产负债表 25
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $222M | $76M | · | |
| Receivables | $35M | $23M | · | |
| Inventory | $4M | $3M | · | |
| Prepaid Expense | $8M | $7M | · | |
| Other Current Assets | $2M | $2M | · | |
| Current Assets | $273M | $113M | · | |
| PP&E (Net) | $8M | $6M | · | |
| PP&E (Gross) | $20M | $16M | · | |
| Accum. Depreciation | $12M | $10M | · | |
| Goodwill | $13M | $13M | · | |
| Intangibles | $2M | $4M | · | |
| Other Non-current Assets | $165.0K | $5M | · | |
| Total Assets | $305M | $151M | · | |
| Accounts Payable | $10M | $4M | · | |
| Accrued Liabilities | $40M | $30M | · | |
| Current Liabilities | $76M | $54M | · | |
| Other Non-current Liabilities | $0 | $285.0K | · | |
| Total Liabilities | $76M | $86M | · | |
| Long-term Debt | $0 | $30M | · | |
| Common Stock | $58.0K | $8.0K | · | |
| Paid-in Capital | $686M | $60M | · | |
| Retained Earnings | $-457M | $-444M | · | |
| Stockholders' Equity | $230M | $-384M | $-350M | |
| Liabilities + Equity | $305M | $151M | · | |
| Shares Outstanding | 58,429,000 | 8,157,000 | 7,388,000 |
现金流 10
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $5M | $5M | $4M | |
| Stock-based Comp | $13M | $9M | $9M | |
| Amort. of Intangibles | $2M | $2M | $2M | |
| Other Non-cash | $13M | · | · | |
| Operating Cash Flow | $18M | $-34M | $-50M | |
| CapEx | $1M | $596.0K | $416.0K | |
| Investing Cash Flow | $-6M | $-4M | $-3M | |
| Financing Cash Flow | $133M | $-1M | $179.0K | |
| Net Change in Cash | $146M | $-39M | $-52M | |
| Free Cash Flow | $17M | · | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 65.7% | · | · | |
| Operating Margin | -4.6% | · | · | |
| Net Margin | -4.9% | · | · | |
| Pretax Margin | -4.9% | · | · | |
| EBITDA Margin | -2.5% | · | · | |
| ROA | -5.6% | · | · | |
| ROE | -5.8% | · | · | |
| ROIC | -5.2% | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.6 | · | · | |
| Quick Ratio | 3.4 | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 1.1 | · | · | |
| Inventory Turnover | 22.9 | · | · | |
| Receivables Turnover | 9.0 | · | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 53.2% | 38.3% | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $260M | · | · | |
| Net Income TTM | $-13M | · | · | |
| Market Cap | $922M | · | · | |
| P/E | -45.1 | · | · | |
| P/S | 3.5 | · | · | |
| P/B | 4.0 | · | · | |
| P / Tangible Book | 4.3 | · | · | |
| P / Cash Flow | 50.5 | · | · | |
| P / FCF | 54.5 | · | · | |
| Earnings Yield | -2.2% | · | · |
损益表 17
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78M | $76M | $68M | $61M | $55M | $48M | $46M | |
| Cost of Revenue | $29M | $22M | $23M | $21M | $23M | $16M | $17M | |
| Gross Profit | $49M | $54M | $45M | $40M | $32M | $32M | $29M | |
| R&D Expense | $13M | $12M | $10M | $10M | $9M | $9M | $9M | |
| SG&A Expense | $14M | $14M | $14M | $12M | $11M | $12M | $11M | |
| Operating Expenses | $53M | $50M | $48M | $45M | $40M | $39M | $37M | |
| Operating Income | $-5M | $3M | $-3M | $-4M | $-8M | $-7M | $-9M | |
| Interest Income | $2M | $2M | $2M | $863.0K | $542.0K | $174.0K | $17.0K | |
| Other Non-op | $2M | $2M | $-665.0K | $-967.0K | $-1M | $-1M | $-702.0K | |
| Pretax Income | $-3M | $5M | $-3M | $-5M | $-9M | $-8M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $5M | $-3M | $-5M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $-0.05 | $0.26 | $-0.06 | $-0.24 | $-1.15 | $-1.02 | $-1.18 | |
| EPS (Diluted) | $-0.05 | $0.26 | $-0.06 | $-0.24 | $-1.15 | $-1.02 | $-1.18 | |
| Shares (Basic) | 58,923,000 | 7,218,000 | 57,658,000 | 21,971,000 | 8,241,000 | 77,000 | 7,788,000 | |
| Shares (Diluted) | 58,923,000 | 7,218,000 | 57,658,000 | 21,971,000 | 8,241,000 | 77,000 | 7,788,000 | |
| EBITDA | $-3M | · | $-3M | $-4M | · | · | · |
资产负债表 25
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $212M | $222M | $199M | $223M | · | $76M | · | |
| Receivables | $40M | $35M | $41M | $33M | · | $23M | · | |
| Inventory | $4M | $4M | $3M | $3M | · | $3M | · | |
| Prepaid Expense | $10M | $8M | $8M | $8M | · | $7M | · | |
| Other Current Assets | · | $2M | · | · | · | $2M | · | |
| Current Assets | $269M | $273M | $255M | $271M | · | $113M | · | |
| PP&E (Net) | $8M | $8M | $8M | $6M | · | $6M | · | |
| PP&E (Gross) | · | $20M | · | · | · | $16M | · | |
| Accum. Depreciation | · | $12M | · | · | · | $10M | · | |
| Goodwill | $13M | $13M | $13M | $13M | · | $13M | · | |
| Intangibles | $2M | $2M | $3M | $3M | · | $4M | · | |
| Other Non-current Assets | $226.0K | $165.0K | $199.0K | $234.0K | · | $5M | · | |
| Total Assets | $303M | $305M | $287M | $303M | · | $151M | · | |
| Accounts Payable | $8M | $10M | $5M | $7M | · | $4M | · | |
| Accrued Liabilities | $31M | $40M | $38M | $25M | · | $30M | · | |
| Current Liabilities | $69M | $76M | $70M | $58M | · | $54M | · | |
| Other Non-current Liabilities | $0 | $0 | $0 | $373.0K | · | $285.0K | · | |
| Total Liabilities | $69M | $76M | $70M | $89M | · | $86M | · | |
| Long-term Debt | · | $0 | $0 | $30M | · | $30M | · | |
| Common Stock | $59.0K | $58.0K | $58.0K | $56.0K | · | $8.0K | · | |
| Paid-in Capital | $694M | $686M | $679M | $673M | · | $60M | · | |
| Retained Earnings | $-460M | $-457M | $-462M | $-459M | · | $-444M | · | |
| Stockholders' Equity | $234M | $230M | $217M | $214M | · | $-384M | · | |
| Liabilities + Equity | $303M | $305M | $287M | $303M | · | $151M | · | |
| Shares Outstanding | 59,240,000 | 58,429,000 | 57,887,000 | 57,321,000 | · | 8,157,000 | · |
现金流 9
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $4M | $4M | $4M | $3M | $3M | $2M | $2M | |
| Other Non-cash | $-15M | · | · | · | · | · | · | |
| Operating Cash Flow | $-12M | $21M | $10M | $3M | $-16M | $-6M | $1M | |
| CapEx | $78.0K | $199.0K | $537.0K | $271.0K | $315.0K | $184.0K | $76.0K | |
| Investing Cash Flow | $-2M | $-1M | $-2M | $-1M | $-1M | $-969.0K | $-1M | |
| Financing Cash Flow | $3M | $3M | $-33M | $162M | $372.0K | $113.0K | $-424.0K | |
| Net Change in Cash | $-10M | $23M | $-25M | $164M | $-17M | $-7M | $-436.0K | |
| Free Cash Flow | $-12M | · | · | · | · | · | · |
盈利能力 8
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.4% | · | 66.2% | 65.7% | · | · | · | |
| Operating Margin | -6.1% | · | -3.7% | -7.1% | · | · | · | |
| Net Margin | -3.8% | · | -4.7% | -8.6% | · | · | · | |
| Pretax Margin | -3.8% | · | -4.7% | -8.6% | · | · | · | |
| EBITDA Margin | -4.2% | · | -3.7% | -7.1% | · | · | · | |
| ROA | -2.0% | · | -2.2% | -3.5% | · | · | · | |
| ROE | -2.5% | · | -2.9% | -5.0% | · | · | · | |
| ROIC | -2.0% | · | -1.2% | -2.0% | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | · | 3.6 | 4.7 | · | · | · | |
| Quick Ratio | 3.7 | · | 3.4 | 4.4 | · | · | · |
效率 3
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.5 | 0.4 | · | · | · | |
| Inventory Turnover | 15.3 | · | 14.6 | 12.1 | · | · | · | |
| Receivables Turnover | 3.9 | · | 3.3 | 3.7 | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $262M | · | · | · | · | · | · | |
| Net Income TTM | $-21M | · | $-27M | $-35M | · | · | · | |
| Market Cap | $745M | · | $1.28B | $1.05B | · | · | · | |
| P/E | -8.4 | · | · | · | · | · | · | |
| P/S | 2.8 | · | · | · | · | · | · | |
| P/B | 3.2 | · | 5.9 | 4.9 | · | · | · | |
| P / Tangible Book | 3.4 | · | 6.4 | 5.3 | · | · | · | |
| P / Cash Flow | -62.9 | · | · | · | · | · | · | |
| P / FCF | -62.5 | · | · | · | · | · | · | |
| Earnings Yield | -11.9% | · | · | · | · | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 收入 | $260M | $170M | $123M |
| 毛利率 % | 65.7% | — | — |
| 营业利润率 % | -4.6% | — | — |
| 净收入 | $-13M | $-47M | $-68M |
| 稀释后每股收益 (EPS) | $-0.35 | $-6.11 | $-9.52 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 流动比率 | 3.6 | — | — |
| 速动比率 | 3.4 | — | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 自由现金流 | $17M | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。